Novartis AG (NVS)
103.85
+0.76
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
103.80
-0.05
(-0.05%)
After-Hours: 20:00
Novartis Profit Margin (Quarterly): 24.21% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 24.21% |
| June 30, 2024 | 25.22% |
| March 31, 2024 | 22.18% |
| December 31, 2023 | 72.01% |
| September 30, 2023 | 14.56% |
| June 30, 2023 | 19.72% |
| March 31, 2023 | 20.76% |
| December 31, 2022 | 13.37% |
| September 30, 2022 | 14.59% |
| June 30, 2022 | 12.95% |
| March 31, 2022 | 17.34% |
| December 31, 2021 | |
| September 30, 2021 | 20.63% |
| June 30, 2021 | 21.78% |
| March 31, 2021 | 16.22% |
| December 31, 2020 | 16.07% |
| September 30, 2020 | 15.43% |
| June 30, 2020 | 16.06% |
| March 31, 2020 | 17.12% |
| December 31, 2019 | 8.85% |
| September 30, 2019 | 16.36% |
| June 30, 2019 | 56.55% |
| March 31, 2019 | 15.42% |
| December 31, 2018 | 10.04% |
| September 30, 2018 | 14.25% |
| Date | Value |
|---|---|
| June 30, 2018 | 66.66% |
| March 31, 2018 | 18.14% |
| December 31, 2017 | 30.72% |
| September 30, 2017 | 16.40% |
| June 30, 2017 | 15.85% |
| March 31, 2017 | 14.14% |
| December 31, 2016 | 7.59% |
| September 30, 2016 | 15.72% |
| June 30, 2016 | 14.23% |
| March 31, 2016 | 17.03% |
| December 31, 2015 | 8.23% |
| September 30, 2015 | 15.12% |
| June 30, 2015 | 14.24% |
| March 31, 2015 | |
| December 31, 2014 | 11.17% |
| September 30, 2014 | 24.23% |
| June 30, 2014 | 18.32% |
| March 31, 2014 | 22.57% |
| December 31, 2013 | 14.89% |
| September 30, 2013 | 17.29% |
| June 30, 2013 | 18.95% |
| March 31, 2013 | 16.88% |
| December 31, 2012 | 20.94% |
| September 30, 2012 | 17.02% |
| June 30, 2012 | 18.21% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
8.85%
Minimum
Dec 2019
72.01%
Maximum
Dec 2023
20.48%
Average
17.12%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 10.53% |
| Johnson & Johnson | 11.99% |
| Eli Lilly and Co | 8.48% |
| Novo Nordisk AS | 38.28% |
| Monte Rosa Therapeutics Inc | -258.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.89% |
| Return on Assets | 17.33% |
| Return on Invested Capital | 25.80% |
| Gross Profit Margin (Quarterly) | 75.45% |
| Operating Margin (Quarterly) | 27.54% |
| Return on Net Operating Assets | 22.97% |